Clinical Trials Directory

Trials / Unknown

UnknownNCT05061082

Genomic Evolution of Metastasis in Gastric Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
University Medical Center Ho Chi Minh City (UMC) · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to track tumor evolution of regional and distant metastases in gastric cancer using the Next Generation Sequencing technologies.

Detailed description

Gastric cancer is the fourth most common cancer in Vietnam with high mortality rate. Metastasis is the leading cause of death in gastric cancer patients, with median overall survival of less than 1 year. Currently, there is no effective treatment because the molecular mechanism of metastasis remains unclear. The aim of this study is to use advanced NGS technologies to dissect the genomic changes (genetic, epigenetic and transcriptional changes) of the primary tumor and associated metastatic sites of the same patients. With that, the investigators can reconstruct the clonal evolution from primary tumor to metastasis, identify key pathways governing metastasis development that can be targeted for future therapeutic development.

Conditions

Timeline

Start date
2021-10-26
Primary completion
2022-10-31
Completion
2022-10-31
First posted
2021-09-29
Last updated
2022-04-28

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT05061082. Inclusion in this directory is not an endorsement.